| Dr Manisha N Patel, MD | |
|
200 Scenery Dr, State College, PA 16801-7974 | |
| (814) 231-4560 | |
| (814) 231-6246 |
| Full Name | Dr Manisha N Patel |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 30 Years |
| Location | 200 Scenery Dr, State College, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063477628 | NPI | - | NPPES |
| 101472457 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD427951 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Geisinger Medical Center | Danville, PA | Hospital |
| Mount Nittany Medical Center | State college, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Phoenix Rehabilitation And Health Services Inc | 3476464298 | 51 |
| Geisinger Clinic | 5395657001 | 2866 |
News Archive
While young people with parasite worms currently have four times higher risk for developing allergies and asthma than others. Their parents are generally unaffected.
A Ugandan-UK Healthcare Alliance, which will help improve health care for people living in the East African country, has been launched this week after being developed by a University of Manchester health professional.
The Los Angeles Times reports that, for Californians, the state's largest insurers are likely to stick with, or even reduce, the size of their doctor networks for the upcoming plan season. Additionally, no comprehensive directory is available to help consumers match their physicians with their health plans. Meanwhile, The Washington Post also explores how the issue is playing out in the context of a ballot initiative.
Probiotics are one of the fastest growing areas for research as well as one of the valued members in the food industry. These are healthy bacteria or friendly bacteria that are added to yogurts, drinks, and baby food in order to colonize out gut when we are taking antibiotics or are down with an intestinal infection.
Pfizer Inc. announced that the Phase 3 INTORACT trial (B1771006), evaluating the combination of bevacizumab plus TORISEL (temsirolimus) compared with bevacizumab plus interferon-alfa-2a (IFN-α-2a) in the first-line treatment of patients with advanced renal cell carcinoma (RCC) across risk groups, did not meet its primary endpoint of superiority in extending progression free survival (PFS) in the study population.
› Verified 2 days ago
| Entity Name | Geisinger Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366493868 PECOS PAC ID: 5395657001 Enrollment ID: O20040130000518 |
News Archive
While young people with parasite worms currently have four times higher risk for developing allergies and asthma than others. Their parents are generally unaffected.
A Ugandan-UK Healthcare Alliance, which will help improve health care for people living in the East African country, has been launched this week after being developed by a University of Manchester health professional.
The Los Angeles Times reports that, for Californians, the state's largest insurers are likely to stick with, or even reduce, the size of their doctor networks for the upcoming plan season. Additionally, no comprehensive directory is available to help consumers match their physicians with their health plans. Meanwhile, The Washington Post also explores how the issue is playing out in the context of a ballot initiative.
Probiotics are one of the fastest growing areas for research as well as one of the valued members in the food industry. These are healthy bacteria or friendly bacteria that are added to yogurts, drinks, and baby food in order to colonize out gut when we are taking antibiotics or are down with an intestinal infection.
Pfizer Inc. announced that the Phase 3 INTORACT trial (B1771006), evaluating the combination of bevacizumab plus TORISEL (temsirolimus) compared with bevacizumab plus interferon-alfa-2a (IFN-α-2a) in the first-line treatment of patients with advanced renal cell carcinoma (RCC) across risk groups, did not meet its primary endpoint of superiority in extending progression free survival (PFS) in the study population.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Manisha N Patel, MD 100 N Academy Ave, Danville, PA 17822-3034 Ph: (570) 271-6144 | Dr Manisha N Patel, MD 200 Scenery Dr, State College, PA 16801-7974 Ph: (814) 231-4560 |
News Archive
While young people with parasite worms currently have four times higher risk for developing allergies and asthma than others. Their parents are generally unaffected.
A Ugandan-UK Healthcare Alliance, which will help improve health care for people living in the East African country, has been launched this week after being developed by a University of Manchester health professional.
The Los Angeles Times reports that, for Californians, the state's largest insurers are likely to stick with, or even reduce, the size of their doctor networks for the upcoming plan season. Additionally, no comprehensive directory is available to help consumers match their physicians with their health plans. Meanwhile, The Washington Post also explores how the issue is playing out in the context of a ballot initiative.
Probiotics are one of the fastest growing areas for research as well as one of the valued members in the food industry. These are healthy bacteria or friendly bacteria that are added to yogurts, drinks, and baby food in order to colonize out gut when we are taking antibiotics or are down with an intestinal infection.
Pfizer Inc. announced that the Phase 3 INTORACT trial (B1771006), evaluating the combination of bevacizumab plus TORISEL (temsirolimus) compared with bevacizumab plus interferon-alfa-2a (IFN-α-2a) in the first-line treatment of patients with advanced renal cell carcinoma (RCC) across risk groups, did not meet its primary endpoint of superiority in extending progression free survival (PFS) in the study population.
› Verified 2 days ago
Paul Andrew Koberna, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2134 Sandy Dr Ste 16, State College, PA 16803 Phone: 814-272-5805 Fax: 814-272-0110 | |
Peter F. Pepe, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1850 E Park Ave, Suite 201, State College, PA 16803 Phone: 814-234-8800 | |
Keriann Nickola Gray, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Scenery Dr., State College, PA 16801 Phone: 814-231-4560 Fax: 814-231-6246 | |
Dr. Joel B Haight, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 32 Colonnade Way, State College, PA 16803 Phone: 814-272-4445 Fax: 814-272-4450 | |
Jeffrey W. Pro, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1850 E Park Ave, Suite 302, State College, PA 16803 Phone: 814-278-4680 Fax: 814-235-1523 | |
Dr. Scott A. Sulman, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Scenery Dr, State College, PA 16801 Phone: 814-231-4560 Fax: 814-235-5512 |